- Telehealth Visits
- Insurance plan information
Tracy J. Peng, MD
Psychosomatic Medicine • Psychiatry- Telehealth Visits
- Insurance plan information
Tracy J. Peng, MD
Psychosomatic Medicine • Psychiatry- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Tracy Peng is an integrative psychiatrist, a specialist in combining conventional and complementary therapies as appropriate. Her special interests include mindfulness approaches to psychotherapy and the use of both standard and herbal medications to treat anxiety and depression. She also specializes in providing spiritually focused psychotherapy to women with cancer.
In addition to treating patients, Peng teaches in the UCSF Department of Psychiatry.
Peng received her medical degree from the Keck School of Medicine of the University of Southern California. She completed a psychiatry residency at California Pacific Medical Center. She is also a graduate of the Zen Hospice Project’s program for providers of end-of-life care.
Education & training
Board certification
- Psychiatry, American Board of Psychiatry and Neurology
Residency
- Psychiatry, California Pacific Medical Center - Sutter Health
Internship
- Psychiatry, California Pacific Medical Center - Sutter Health
Degree
- MD, University of Southern California
My expertise
Specialties
- Psychosomatic Medicine
- Psychiatry
Conditions
Treatments
- Integrative Psychotherapy
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%22865%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%22865%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.